View full profile on the Yale School of Public Health website
Education
- PhD, Yale University, 1992
- MBA, Yale University, 1985
- BA, McGill University, 1981
Selected Articles
The survival benefits of Antiretroviral Therapy in South Africa
Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania
A marginal benefit approach for vaccinating influenza ‘superspreaders’
The Cost-Effectiveness of HIV Treatment as Prevention: Analysis of HPTN 052
Placing a Price on Medical Device Innovation: The Example of Total Knee Arthroplasty
Achievements
- Connecticut Academy of Science and Engineering, Elected as Member, 2014
- Institute of Medicine, Committee on Valuing Community-Based, Non-Clinical Prevention Policies and Wellness Strategies, 2011
- Scientific Advisory Committee, French National Agency for Research on AIDS (ANRS), 2009-2013
- Institute of Medicine, Committee on Review of Priorities in the National Vaccine Plan, 2008-2009
- Institute of Medicine, Committee on Community Mitigation Strategies for Influenza Pandemic, 2006-2007
- Institute of Medicine, Committee on the President's Emergency Plan for AIDS Relief (PEPFAR), 2005-2007
- Society for Medical Decision Making, Secretary-Treasurer and Executive Committee member, 2006-
- Institute of Medicine, Committee on the Ryan White CARE Act: Planning and Evaluation, 2002-2004
Consultancies
- Institute of Medicine
- Brigham and Women’s Hospital
- Massachusetts General Hospital
- Weill Medical College of Cornell University